2008　論文・総説（英語） Publications（International）

1	Graciano M.L., Nishiyama A, Jackson K, Seth DM, Ortiz RM, Prieto-Carrasquero M, Kobori H and Navar LG. Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension. Am. J. Physiol. Renal Physiology. 294: F161-F169, 2008
2	Kiyomoto H and Nishiyama A. Do vasculature reactive oxygen species play a role in the mobilization of bone marrow endothelial progenitor cells? J. Hypertens. 26: 188-190, 2008.
3	Nakano D, Kurumazuka D, Nagai Y, Nishiyama A, Kiso Y and Matsumura Y. Dietary sesamin suppresses the aortic NADPH oxidase in DOCA-salt hypertensive rat. Clin. Exp. Pharmacol. Physiol. 35:324-326, 2008
4	Miyata K, Sun G-P, Guo P, Hitomi H, Kimura S, Kiyomoto H, Hosomi N, Kohno M and Nishiyama A. Possible involvement of Rho-kinase in aldosterone-induced vascular remodeling. Hypertens. Res. 31;1407-1413, 2008.
5	Nishiyama A, Nakagawa T, Kobori H, Nagai Y, Okada N, Konishi Y, Morikawa T, Okumura M, Meda I, Kiyomoto H, Hosomi N, Mori T, Ito S, Imanishi M. Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria. J. Hypertens. 26;1849-1859, 2008.
6	Nakano D, Kiyomoto H, Nishiyama A. The efficacy of gene therapy for TGF-b in progressive diabetic nephropathy. Clin. Exp. Pharmacol. Physiol. 35:1275-1276, 2008.
7	Konishi Y, Morikawa T, Okada N, Maeda I, Kitabayashi C, Yoshioka K, Okumura M, Nishiyama A, Ueda M, Takai S, Miyazaki M, Imanishi M. Evidence for abundant presence of chymase-positive mast cells in the kidneys of patients with immunoglobulin A nephropathy: Effect of combination therapy with prednisolone and angiotensin II receptor blocker valsartan. Hypertens. Res.31:1517-1524, 2008.
8	Akiyama K, Miyashita T, Matsubara A, Mori T, Inamoto R, Nishiyama A, Mori N. A new approach for selective rat endolymphatic sac epithelium collection to obtain pure specific RNA. Biochem. Biophys. Res. Commun. 376:611-614, 2008.
9	Kiyomoto H, Rafiq K, Mostofa M, Nishiyama A. Possible underlying mechanisms responsible for aldosterone and mineralocorticoid receptor-dependent renal injury. J. Pharmacol. Sci. 108:399-405, 2008.
10	Diah S, Zhang G-X, Hitomi H, Nagai Y, Zhang W, Gang L, Kimura S, Hamid MRWA, Tamiya T, Nishiyama A. Aldosterone induces myofibroblastic transdifferentiation and collagen gene expression through Rho-kinase dependent signaling pathway in rat mesangial cells. Exp Cell Res. 314:3654-3662, 2008.
11	Nakano D, Pollock JS, Pollock DM. Renal medullary ETB receptors produce diuresis and natriuresis via NOS1. Am. J. Physiol. Renal Physiology. 294: F1205-F1211, 2008.
13	Akira Nishiyama, Hirofumi Hitomi, Hideyasu Kiyomoto. Mineralocorticoid receptor blocker. Nippon yakurigaku zasshi. Folia pharmacologica Japonica 132 244 - 246 2008.
14	Atsuhiro Ichihara, Mariyo Sakoda, Asako Kurauchi-Mito, Akira Nishiyama, Hiroshi Itoh. Involvement of receptor-bound prorenin in development of nephropathy in diabetic db/db mice. JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION 2(5) 332 - 340 2008.
15	M. Sakoda, A. Ichihara, A. Mito-Kurauchi, A. Nishiyama, H. Iwata, T. Nakagawa, F. Suzuki, Y. Kaneshiro, M. A. Saleen, H. Itoh. Effects of renin inhibition on activated prorenin in human podocytes. JOURNAL OF HYPERTENSION 26 S199 - S199 2008.
16	Shinji Kume, Kunio Hirata, Shin-Ici Araki, Akira Nishiyama, Toshiro Sugimoto, Daisuke Koya, Masa-Kazu Haneda, Takashi Uzu, Atsunori Kashiwagi. A GLP-1 analog, exendin-4, attenuates the developments of renal injury and hypertension in type 2 diabetic db/db mice. DIABETES 57 A205 - A206 2008.
17	Yasutaka Maeda, Toyoshi Inoguchi, Shuji Sasaki, Masakazu Fujii, Kunihisa Kobayashi, Hidenori Urata, Akira Nishiyama, Ryoichi Takayanagi. Chymase inhibitor prevented diabetic nephropathy via attenuation of oxidative stress and NAD(P)H oxidase expression in diabetic hamsters. DIABETES 57 A209 - A209 2008.